Pharmaceutical UK specialty drugmaker Sinclair IS Pharma plc (AIM: SPH.L) has entered into an agreement to acquire USA-based Advanced Bio-Technologies (ABT), a dermatological products company focused on scar treatment and prevention from HealthEdge Investment Partners, and certain other shareholders for a total consideration of 21.0 million ($32.8 million). 8 December 2011